|
References: E, F
- Einfeld, S., B. Tonge, and G. Turner. 1999. Longitudinal course of behavioral and emotional problems in fragile X syndrome. Am. J. Med. Genet. 87:436-439.
- Evans, R. W., and C. T. Gualtieri. 1985. Carbamazepine neurophysiological and psychiatric profile. Clin. Neuropharmacol. 8:221-241.
- Fairbanks, J. M., D. S. Pine, N. K. Tancer, E. S. Dummit 3d, L. M. Kentgen, J. Martin, B. K. Asche, and R. G. Klein. 1997. Open fluoxetine treatment of mixed anxiety disorders in children and
adolescents. J. Child Adolesc. Psychopharmacol. 7:17-29.
- Fenichel, R. F. 1995. Combining methylphenidate and clonidine: The role of post-marketing surveillance. J. Child Adolesc. Psychopharmacol. 5:155-156.
- Findling, R. L., and J. W. Dogin. 1998. Psychopharmacology of ADHD: Children and adolescents. J. Clin. Psychiatry 59:42-49.
- Findling, R. L., S. J. Grcevich, I. Lopez, and S. C. Schulz. 1996a. Antipsychotic medications in children and adolescents. J. Clin. Psychiatry 57:19-23.
- Findling, R. L., M. A. Schwartz, D. J. Flannery, and M. J. Manos. 1996b. Venlafaxine in adults with attention-deficit/hyperactivity disorder: An open clinical trial [see comments]. J. Clin. Psychiatry
57:184-189.
- Findling, R. L., K. Maxwell, and M. Wiznitzer. 1997. An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol. Bull. 33:155-159.
- Findling, R. L., S. C. Schulz, M. D. Reed, and J. L. Blumer. 1998. The antipsychotics: A pediatric perspective. Pediatr. Clin. North Am. 45:1205-1232.
- Findling, R. L., N. K. McNamara, L. A. Branicky, M. D. Schluchter, E. Lemon, and J. L. Blumer. 2000. A double-blind pilot study of risperidone in the treatment of conduct disorder. J. Am. Acad. Child
Adolesc. Psychiatry 39:509-516.
- Fisch, G. S., I. L. Cohen, A. C. Gross, V. Jenkins, E. C. Jenkins, and W. T. Brown. 1988. Folic acid treatment of fragile X males: A further study. Am. J. Med. Genet. 30:393-399.
- Fragile X Society (England). 1995. Bowel control questionnaire. Fragile X Society Newsletter 11:11-12.
- Fras, I., and L. F. Major. 1995. Clinical experience with risperidone [letter]. J. Am. Acad. Child Adolesc. Psychiatry 34:833.
- Freeman, T. W., J. L. Clothier, P. Dazzaglia, M. D. Lesem, and A. C. Swann. 1992. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am. J. Psychiatry 149:108-111.
- Froster-Iskenius, U., K. Bodeker, T. Oepen, R. Matthes, U. Piper, and E. Schwinger. 1986. Folic acid treatment in males and females with fragile(X) syndrome. Am. J. Med. Genet. 23:273-289.
- Fryns, J. P. 1994. Massive hydrocele in post pubertal fra (X) males [letter]. Am. J. Med. Genet. 49:259.
- Fryns, J. P., P. Moerman, F. Gilis, L. d'Espallier, and H. Van den Berghe. 1988. Suggestively increased incidence of sudden death in children of fra(X) positive mothers. Am. J. Med. Genet. 30:73-75.
|
This article is not intended to give medical advice for individual cases. Any change in medical treatment
should be done in consultation with appropriate medical personnel. This article is written for medical professionals. Some of the terms will be unfamiliar to those who are not trained in medical fields.
*This article is from the chapter on treatment in the 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research edited
by Randi Jenssen Hagerman, M.D. and Paul Hagerman, M.D., Ph.D., to be published May 2002. It is included with permission from The Johns Hopkins University Press. References to other chapters refer to chapters in
the book which are not included as part of this website.
The complete 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research can be ordered from the National Fragile X Foundation by calling
1-800-688-8765 or from The Johns Hopkins University Press at 1-800-537-5487.
|
|
Medical Follow-up Pharmacotherapy Future Prospects
Outline Medications Medical Conditions
References: A, B, C, D, EF, G, H, IJ, K, L, M, NOP, QR, S, T, UVWXYZ
|
